Interesting study that identifies a novel muscle-tendon progenitor (MTP) cell population in the myotendinous junction, and touches on MTP's potential as a cell therapy for challenging MTJ injuries: https://t.co/NrAmc1ttnF #bioe610
Hydrogels made from modified amyloid peptides - which make up the plaques found in #Alzheimers - enhance differentiation of #MSCs into neurons #bioe610: https://t.co/tlcDPkezeF
Fresh off the press! This fascinating article aims to help elucidate cellular mechanisms regulating osteoarthritis. Here, the Runx family is evaluated in three OA in vivo models. Worth a read!
https://t.co/3ER3Zyktg9
#BioE610
Here's a cool paper: NicheNet predicts the most powerful ligand-receptor pairs between interacting cells by analyzing changes in gene regulation. Could be a useful tool for designing or characterizing #tissueengineering strategies! #bioe610
https://t.co/uuPkSr3XAP
🗞️Hot off the press🗞️ MSC-derived EV's "exert a critical therapeutic effect" for #osteoarthritis treatment. They're also a readily-engineerable drug delivery platform with distinct advantages over direct cell delivery @BioMedCentral#bioe610
https://t.co/ENnqIdyvlr
It was a great day of science at #OregonBioengineeringSympsoium!!! Lab members Julia Harrer, @Yan_CarlosP, and Harper McClain did an excellent job presenting on new bone and muscle regen strategies
✅ first conference with @WillettLabs at the Oregon Bioengineering Symposium! It was great to meet so many sharp scientists and learn about the incredible research happening in Oregon's BioE community
Interested in gaining clearer insight into a few potential directions osteoarthritis treatment may take in the future?
Then check out this thorough and clinically-relevant review article here: https://t.co/QIi4x9iaBx
Whew, what a week! And what a great group of bioengineering Ph.D. students! That's a wrap for #ImpactWeek at the #KnightCampus. The bootcamp may be over, but the personal and professional growth will continue! https://t.co/FVXPmqNx3F